WSK-IM02 in Advanced Solid Tumors With Malignant Effusions (Phase I)

Summary

This is a prospective, single-center, interventional, phase I, dose-escalation, single-arm study designed to evaluate the safety, tolerability, and preliminary efficacy of intrapleural/intraperitoneal infusion of WSK-IM02 in patients with advanced solid tumors complicated by malignant pleural or peritoneal effusions who have failed standard of care.

Timeline

Start

2026-06-01

Primary completion

2028-01-30

Completion

2029-06-30

Drugs

Indications